Report for Lyketsos CG

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (10)

Title : Translating clinical notes into quantitative measures-a real-world observation on the response to cholinesterase inhibitors or selective serotonin reuptake inhibitors prescribed to outpatients with dementia using electronic medical records - Chotiyanonta_2023_Front.Pharmacol_14_1177026
Author(s) : Chotiyanonta JS , Onda K , Nowrangi MA , Li X , Xu X , Adams R , Lyketsos CG , Zandi P , Oishi K
Ref : Front Pharmacol , 14 :1177026 , 2023
Abstract : Chotiyanonta_2023_Front.Pharmacol_14_1177026
ESTHER : Chotiyanonta_2023_Front.Pharmacol_14_1177026
PubMedSearch : Chotiyanonta_2023_Front.Pharmacol_14_1177026
PubMedID: 37234714

Title : Psychosis in Alzheimer disease - mechanisms, genetics and therapeutic opportunities - Ismail_2022_Nat.Rev.Neurol__
Author(s) : Ismail Z , Creese B , Aarsland D , Kales HC , Lyketsos CG , Sweet RA , Ballard C
Ref : Nat Rev Neurol , : , 2022
Abstract : Ismail_2022_Nat.Rev.Neurol__
ESTHER : Ismail_2022_Nat.Rev.Neurol__
PubMedSearch : Ismail_2022_Nat.Rev.Neurol__
PubMedID: 34983978

Title : Use of FDA approved medications for Alzheimer's disease in mild dementia is associated with reduced informal costs of care - Behrens_2018_Int.Psychogeriatr__1
Author(s) : Behrens S , Rattinger GB , Schwartz S , Matyi J , Sanders C , DeBerard MS , Lyketsos CG , Tschanz JT
Ref : Int Psychogeriatr , :1 , 2018
Abstract : Behrens_2018_Int.Psychogeriatr__1
ESTHER : Behrens_2018_Int.Psychogeriatr__1
PubMedSearch : Behrens_2018_Int.Psychogeriatr__1
PubMedID: 29559029

Title : Population pharmacokinetic modeling of sertraline treatment in patients with Alzheimer disease: the DIADS-2 study -
Author(s) : Li CH , Pollock BG , Lyketsos CG , Vaidya V , Drye LT , Kirshner M , Sorisio D , Bies RR
Ref : Journal of Clinical Pharmacology , 53 :234 , 2013
PubMedID: 23436269

Title : Effects of Food and Drug Administration-approved medications for Alzheimer's disease on clinical progression - Mielke_2012_Alzheimers.Dement_8_180
Author(s) : Mielke MM , Leoutsakos JM , Corcoran CD , Green RC , Norton MC , Welsh-Bohmer KA , Tschanz JT , Lyketsos CG
Ref : Alzheimers Dement , 8 :180 , 2012
Abstract : Mielke_2012_Alzheimers.Dement_8_180
ESTHER : Mielke_2012_Alzheimers.Dement_8_180
PubMedSearch : Mielke_2012_Alzheimers.Dement_8_180
PubMedID: 22301194

Title : Alterations of the sphingolipid pathway in Alzheimer's disease: new biomarkers and treatment targets? - Mielke_2010_Neuromolecular.Med_12_331
Author(s) : Mielke MM , Lyketsos CG
Ref : Neuromolecular Med , 12 :331 , 2010
Abstract : Mielke_2010_Neuromolecular.Med_12_331
ESTHER : Mielke_2010_Neuromolecular.Med_12_331
PubMedSearch : Mielke_2010_Neuromolecular.Med_12_331
PubMedID: 20571935

Title : Acetylcholinesterase inhibitors in assisted living: patterns of use and association with retention - Rosenblatt_2008_Int.J.Geriatr.Psychiatry_23_178
Author(s) : Rosenblatt A , Samus QM , Onyike CU , Baker AS , McNabney M , Mayer LS , Brandt J , Lyketsos CG
Ref : Int J Geriatr Psychiatry , 23 :178 , 2008
Abstract : Rosenblatt_2008_Int.J.Geriatr.Psychiatry_23_178
ESTHER : Rosenblatt_2008_Int.J.Geriatr.Psychiatry_23_178
PubMedSearch : Rosenblatt_2008_Int.J.Geriatr.Psychiatry_23_178
PubMedID: 17676652

Title : Cholinesterase inhibitors and memantine have a role in the treatment of Alzheimer's disease -
Author(s) : Rabins PV , Lyketsos CG
Ref : Nat Clin Pract Neurol , 2 :578 , 2006
PubMedID: 17057739

Title : Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease - Leroi_2004_Int.J.Geriatr.Psychiatry_19_1
Author(s) : Leroi I , Brandt J , Reich SG , Lyketsos CG , Grill S , Thompson R , Marsh L
Ref : Int J Geriatr Psychiatry , 19 :1 , 2004
Abstract : Leroi_2004_Int.J.Geriatr.Psychiatry_19_1
ESTHER : Leroi_2004_Int.J.Geriatr.Psychiatry_19_1
PubMedSearch : Leroi_2004_Int.J.Geriatr.Psychiatry_19_1
PubMedID: 14716693

Title : Guidelines for the use of tacrine in Alzheimer's disease: clinical application and effectiveness. Johns Hopkins Dementia Research Clinic - Lyketsos_1996_J.Neuropsychiatry.Clin.Neurosci_8_67
Author(s) : Lyketsos CG , Corazzini K , Steele CD , Kraus MF
Ref : J Neuropsychiatry Clin Neurosci , 8 :67 , 1996
Abstract : Lyketsos_1996_J.Neuropsychiatry.Clin.Neurosci_8_67
ESTHER : Lyketsos_1996_J.Neuropsychiatry.Clin.Neurosci_8_67
PubMedSearch : Lyketsos_1996_J.Neuropsychiatry.Clin.Neurosci_8_67
PubMedID: 8845704